Intuitive Surgical, Inc. (ISRG) Return on Assets (ROA): 14.81%
Is Intuitive Surgical, Inc.’s return on assets (ROA) high or low?
Intuitive Surgical, Inc.'s return on assets (ROA) of 14.81% is 27% above its 5-year average of 11.68%, near the high end of its 5-year range (9.50%–13.84%).
The return on assets (ROA) for Intuitive Surgical, Inc. (ISRG) is 14.81% as of Wednesday, June 10, 2026. It is above its 12-month average by 13.18% (13.09%).
ISRG Return on Assets (ROA) Chart
ISRG Average Return on Assets (ROA) Chart
ISRG Current vs Average Return on Assets (ROA) Chart
ISRG Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
14.81%
RETURN ON ASSETS (ROA) AVG TTM
13.09%
RETURN ON ASSETS (ROA) AVG 3Y
12.00%
RETURN ON ASSETS (ROA) AVG 5Y
11.68%
RETURN ON ASSETS (ROA) AVG 10Y
12.13%
RETURN ON ASSETS (ROA) AVG 15Y
13.08%
RETURN ON ASSETS (ROA) AVG 20Y
13.30%
CURRENT VS TTM AVG
+13.18%
CURRENT VS 3Y AVG
+23.42%
CURRENT VS 5Y AVG
+26.80%
CURRENT VS 10Y AVG
+22.10%
CURRENT VS 15Y AVG
+13.22%
CURRENT VS 20Y AVG
+11.31%
ISRG Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | — | 14.81% | 13.09% | 12.00% | 11.68% |
| Pfizer Inc. (PFE) | $146.36B | 3.61% | 3.75% | 6.08% | 7.08% |
| Gilead Sciences, Inc. (GILD) | $151.21B | 16.38% | 7.62% | 7.90% | 6.83% |
| Abbott Laboratories (ABT) | $154.66B | 5.68% | 11.99% | 10.28% | 9.45% |
| Danaher Corporation (DHR) | $130.25B | 4.42% | 4.68% | 5.89% | 6.01% |
| CVS Health Corporation (CVS) | $125.16B | 1.16% | 1.25% | 1.93% | 2.38% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 8.41% | -0.92% | 3.28% | 1.99% |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 6.05% | 6.31% | 6.46% | 7.20% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 16.38% | 6.37% | 11.74% | 14.58% |
| Amgen Inc. (AMGN) | $183.75B | 8.43% | 6.48% | 7.48% | 8.52% |
Asset Efficiency
ROA
14.8%
ROE
17.1%
Intuitive Surgical, Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The return on assets (ROA) for ISRG stock is 14.81%.
- Is Intuitive Surgical, Inc.'s return on assets (ROA) high or low?
- Intuitive Surgical, Inc.'s return on assets (ROA) of 14.81% is 27% above its 5-year average of 11.68%, near the high end of its 5-year range (9.50%–13.84%).
- What is the TTM average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The TTM average return on assets (ROA) for ISRG stock is 13.09%.
- What is the 3Y average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The 3Y average return on assets (ROA) for ISRG stock is 12.00%.
- What is the 5Y average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The 5Y average return on assets (ROA) for ISRG stock is 11.68%.
- What is the 10Y average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The 10Y average return on assets (ROA) for ISRG stock is 12.13%.
- What is the 15Y average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The 15Y average return on assets (ROA) for ISRG stock is 13.08%.
- What is the 20Y average return on assets (ROA) for Intuitive Surgical, Inc. (ISRG)?
- The 20Y average return on assets (ROA) for ISRG stock is 13.30%.
Intuitive Surgical, Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 13.84% |
| 2024-12-31 | 12.33% |
| 2023-12-31 | 11.64% |
| 2022-12-31 | 10.19% |
| 2021-12-31 | 12.58% |
| 2020-12-31 | 9.50% |
| 2019-12-31 | 14.17% |
| 2018-12-31 | 14.37% |
| 2017-12-31 | 11.46% |
| 2016-12-31 | 11.34% |
| 2015-12-31 | 12.00% |
| 2014-12-31 | 10.58% |
| 2013-12-31 | 16.99% |
| 2012-12-31 | 16.18% |
| 2011-12-31 | 16.16% |
| 2010-12-31 | 15.97% |
| 2009-12-31 | 12.85% |
| 2008-12-31 | 13.86% |
| 2007-12-31 | 13.90% |
| 2006-12-31 | 10.72% |
| 2005-12-31 | 18.77% |
| 2004-12-31 | 6.63% |
| 2003-12-31 | -3.05% |
| 2002-12-31 | -20.11% |
| 2001-12-31 | -16.64% |
| 2000-12-31 | -16.48% |
| 1999-12-31 | -53.45% |
| 1998-12-31 | -104.53% |
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa